SAFETY OF THE ASSOCIATION OF RANOLAZINE AND IVABRADINE FOR ANTIANGINAL TREATMENT IN STABLE CORONARY ARTERY DISEASE

被引：0
|
作者：
Lupi, A. [1 ]
Schaffer, A. [2 ]
Mirabelli, F. [3 ]
Rognoni, A. [1 ]
Bongo, A. S. [1 ]
机构：
[1] AOU Maggiore della Carita, Cardiol Div 2, Novara, Italy
[2] Eastern Piedmont Univ, Cardiol Div 1, Vercelli, Italy
[3] ASL Biella, Outpatient Cardiol Serv, Biella, Italy
来源：
CARDIOLOGY | 2016年 / 134卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
097
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [41] Platelet reactivity in patients with coronary artery disease on treatment with ivabradine and clopidogrel: The PLATIVA study
    Virginia Ruiz Pizarro
    David Vivas
    Esther Bernardo
    Aránzazu Ortega
    Cristina Sánchez Enrique
    Daniel Enríquez
    Julián Palacios Rubio
    Isidre Vilacosta
    Antonio Fernández Ortiz
    Carlos Macaya
    Drugs & Therapy Perspectives, 2021, 37 : 222 - 227
  • [42] Selective heart rate reduction with ivabradine increases central blood pressure in stable coronary artery disease
    Cerny, D.
    Messerli, F.
    Laurent, S.
    Seiler, C.
    Rimoldi, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1189 - 1189
  • [43] SELECTIVE HEART RATE REDUCTION WITH IVABRADINE INCREASES CENTRAL BLOOD PRESSURE IN STABLE CORONARY ARTERY DISEASE
    Rimoldi, S.
    Messerli, F. H.
    Cerny, D.
    Laurent, S.
    Seiler, C.
    JOURNAL OF HYPERTENSION, 2016, 34 : E6 - E6
  • [44] Effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease
    Traupe, T.
    Gloekler, S.
    Stoller, M.
    Steck, H.
    Khattab, A. A.
    Vogel, R.
    Seiler, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 567 - 567
  • [45] Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease
    Dillinger, Jean-Guillaume
    Maher, Vincent
    Vitale, Cristiana
    Henry, Patrick
    Logeart, Damien
    Silberman, Stephane Manzo
    Allee, Guillaume
    Levy, Bernard I.
    HYPERTENSION, 2015, 66 (06) : 1138 - 1144
  • [46] Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction
    Cammarano, Carolyn
    Silva, Matthew
    Comee, Morgan
    Donovan, Jennifer L.
    Malloy, Michael J.
    CLINICAL THERAPEUTICS, 2016, 38 (02) : 387 - 395
  • [47] Switching From β-blockers to Ivabradine: Effects on Cardiopulmonary Function in Patients With Stable Coronary Artery Disease and Hypertension
    Fischer-Rasokat, Ulrich
    Honold, Joerg
    Lochmann, Denise
    Liebetrau, Christoph
    Wolter, Sebastian
    Hamm, Christian
    Fichtlscherer, Stephan
    Moellmann, Helge
    Spyridopoulos, Ioakim
    CIRCULATION, 2013, 128 (22)
  • [48] Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease
    Rimoldi, Stefano F.
    Messerli, Franz H.
    Cerny, David
    Gloekler, Steffen
    Traupe, Tobias
    Laurent, Stephane
    Seiler, Christian
    HYPERTENSION, 2016, 67 (06) : 1205 - 1210
  • [49] The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease
    Gloekler, Steffen
    Traupe, Tobias
    Stoller, Michael
    Schild, Deborah
    Steck, Helene
    Khattab, Ahmed
    Vogel, Rolf
    Seiler, Christian
    HEART, 2014, 100 (02) : 160 - 166
  • [50] The acute and chronic effects of ivabradine on the parameters of central aortic pressure in patients with stable coronary artery disease
    Lopatin, Y. M.
    Uskova, V. A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1100 - 1101
12345